Harald Nusser, Head of Novartis Social Business, talks about how the pharmaceutical industry can work with partners to overcome access issues in poor countries.
In an editorial for Pharmaphorum, Dr. Kiliko, Head Customer Services at Mission for Essential Drugs and Supplies (MEDS), showcases how Pharma companies play a vital role in improving access-to-medicines for chronic diseases in developing countries.
Health experts from around the world met November 29 to discuss ways to tackle an emerging crisis.
Humanosphere highlights the work Novartis Access is doing to find a social enterprise solution to help patients in lower-income countries get access to medicines for chronic diseases.
Chronic diseases like high blood pressure and diabetes impact more than just wealthy nations. Through the Novartis Foundation and Novartis Access, we’re working to address the rising threat of chronic diseases in developing countries by improving access to healthcare.
The Novartis Access one-year report describes first results, early learnings and challenges from our first twelve months on the ground. It also includes external perspectives and country updates, showcasing the progress we have made as we roll out the program.
The case study, called "Novartis Access: Democratizing Health Care,” looks at the program and its results so far, as well as lessons learned, challenges and outlook for the future.
Read and download the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society report.
This site is intended for a global audience.